Extensively Drug-resistant Acinetobacter Baumannii Lung Abscess and Empyema in a Patient with Fulminant Mycoplasma Pneumoniae Pneumonia

Overview

Journal Respir Med Case Rep

Date 2025 Jan 15

PMID 39811719

Authors

Siyu Yang

Chaojie Wei

Affiliations

Soon will be listed here.

Abstract

Acinetobacter baumannii is a pathogen that typically causes nosocomial infections. Its resistance to multiple antibiotics poses significant challenges for treatment. Fulminant Mycoplasma pneumoniae pneumonia (FMPP) is relatively rare despite Mycoplasma pneumoniae pneumonia is common among children and young adults. We present a case involving the concurrence of FMPP and lung abscess and empyema caused by extensively drug-resistant (XDR) A.baumanii. The patient was successfully treated through a novel and effective antibacterial regimen combined with timely drainage.

References

Izumikawa K . Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front Microbiol. 2016; 7:800. PMC: 4888638. DOI: 10.3389/fmicb.2016.00800. View

Khoury T, Sviri S, Rmeileh A, Nubani A, Abutbul A, Hoss S . Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study. Clin Microbiol Infect. 2016; 22(8):711-4. DOI: 10.1016/j.cmi.2016.05.028. View

Peleg A, Seifert H, Paterson D . Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3):538-82. PMC: 2493088. DOI: 10.1128/CMR.00058-07. View

Reijnders T, Saris A, Schultz M, van der Poll T . Immunomodulation by macrolides: therapeutic potential for critical care. Lancet Respir Med. 2020; 8(6):619-630. DOI: 10.1016/S2213-2600(20)30080-1. View

Li Z, Wang Y, Chu J, Zhuang Y, Zhang S . Effect of branched-chain amino acids, valine, isoleucine and leucine on the biosythesis of bitespiramycin 4"-O-acylspiramycins. Braz J Microbiol. 2013; 40(4):734-46. PMC: 3768584. DOI: 10.1590/S1517-83822009000400003. View

Unni A, Hidayathulla P, Kavitha K, Paloth M, Nair P, Kumar P J . A fulminant pneumonia due to Mycoplasma pneumoniae - Case report and literature review. IDCases. 2022; 29:e01552. PMC: 9271957. DOI: 10.1016/j.idcr.2022.e01552. View

Davies H, Davies R, Davies C . Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010; 65 Suppl 2:ii41-53. DOI: 10.1136/thx.2010.137000. View

Harding C, Hennon S, Feldman M . Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2017; 16(2):91-102. PMC: 6571207. DOI: 10.1038/nrmicro.2017.148. View

Tamma P, Aitken S, Bonomo R, Mathers A, van Duin D, Clancy C . Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023; . DOI: 10.1093/cid/ciad428. View

10.

Du N, You D, Tenzing D, Qu D, Meng J, Wang Y . Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Infection. Infect Drug Resist. 2024; 17:3617-3621. PMC: 11342940. DOI: 10.2147/IDR.S468413. View

11.

Park J, Yang K, Chung Y, Lee K, Kim J, Kim S . Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant Pneumonia. Antibiotics (Basel). 2021; 10(8). PMC: 8388669. DOI: 10.3390/antibiotics10080903. View

12.

Ma C, Zhou H, Li J, Dai J, He W, Wang H . Construction of 4"-isovalerylspiramycin-I-producing strain by in-frame partial deletion of 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, the bitespiramycin producer. Curr Microbiol. 2010; 62(1):16-20. DOI: 10.1007/s00284-010-9664-8. View

13.

Xing X, Zeng X, Zhang Y, Wang J, Zhang G . Innovative Treatment of Carbapenem-Resistant Pneumonia with Carrimycin: A Case Report. Ann Clin Lab Sci. 2024; 54(4):558-562. View

14.

Mwandumba H, Beeching N . Pyogenic lung infections: factors for predicting clinical outcome of lung abscess and thoracic empyema. Curr Opin Pulm Med. 2000; 6(3):234-9. DOI: 10.1097/00063198-200005000-00012. View

15.

Shen K, Bribriesco A, Crabtree T, Denlinger C, Eby J, Eiken P . The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017; 153(6):e129-e146. DOI: 10.1016/j.jtcvs.2017.01.030. View

16.

Zhu W, Tian Y, Xiang L, Cao L, He L . A Case of Multidrug-Resistant Treated with Carrimycin. Infect Drug Resist. 2023; 16:2365-2369. PMC: 10126721. DOI: 10.2147/IDR.S407076. View

17.

Chan E, Welsh C . Fulminant Mycoplasma pneumoniae pneumonia. West J Med. 1995; 162(2):133-42. PMC: 1022647. View